Position in ADCT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,102,502
-$8,594,325 QoQ
Shares Held
2,899,535
-7.0% QoQ
Ownership
2.27%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 113 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADCT Over Time
Shares Held
Position Value (USD)
Derivatives in ADCT
reported options exposure · as of Jun 30, 2026CallValue
$160,500
CallShares
150,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $1,140,219,030 across 49 Drug Manufacturers - Specialty & Generic names. ADCT ranks #28 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
409,074 | $221,648,565 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
3,853,212 | $179,212,890 | |
| 3 | ZTS |
Zoetis Inc.
|
1,813,759 | $130,336,721 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,265,321 | $110,629,075 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
2,098,945 | $86,119,713 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
2,725,889 | $67,084,128 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
507,207 | $41,986,595 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
336,399 | $37,320,105 |
All Filings in ADCT
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,102,502 | 2,899,535 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $160,500 | 150,000 | Call | Sole | 2026-08-14 | |
| 2026-03-31 | $506,250 | 135,000 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $11,696,827 | 3,119,154 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,159,354 | 328,429 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,806,476 | 701,619 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,028,246 | 383,674 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $232,391 | 164,817 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $818,136 | 411,124 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,244,063 | 712,401 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $316,000 | 100,000 | Call | Sole | 2024-08-14 | |
| 2024-06-30 | $2,580,000 | 816,456 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,536,862 | 1,010,437 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,436,864 | 2,672,810 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,377,275 | 2,650,251 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,061,920 | 1,424,149 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,496,724 | 1,793,192 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $13,060,300 | 3,401,120 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,025,619 | 420,253 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $460,821 | 57,965 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $815,413 | 40,367 | Shares | Sole | 2022-02-14 | |
| 2020-12-31 | $950,024 | 29,679 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,047,333 | 31,747 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $696,860 | 14,887 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||